Bordetella Pertussis Toxin vs Trastuzumab

## Bordetella Pertussis Toxin vs Trastuzumab: Overview

This comparison examines the pharmacological differences between **Bordetella Pertussis Toxin** and **Trastuzumab**.

## Mechanism of Action

**Trastuzumab**: Anti-HER2 monoclonal antibody inhibiting receptor signaling.

## Pharmacokinetics

**Half-life**: Bordetella Pertussis Toxin — N/A; Trastuzumab — 28 days.

## Chemical Properties

**Type**: Bordetella Pertussis Toxin — Vaccine component; Trastuzumab — Antibody.